Av-Phos 250 Neutral
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 67% of ingredients have research evidence
A
Label Compliance Grade
What the Evidence Says
AI-generated · Qwen 3.6 · methodologyThis profile consists of phosphate salts used to provide essential phosphorus and sodium for cellular function and pH balancing. There is strong evidence supporting the role of these minerals in maintaining metabolic processes and bone health. The current formulation maintains a high safety profile based on available data.
AI-generated summary based on research evidence. Not medical advice.
Label
Product Label
Details
Label Data
1 Tablet(s)
Serving Size
100
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients
Supplement Facts — Evidence Check
Market median: 4002.0mg (1 products)
21 studies (A:0, B:2)
Market median: 4002.0mg (1 products)
21 studies (A:0, B:2)
Market median: 4002.0mg (1 products)
21 studies (A:0, B:2)
250 mg
(25% DV)
Within RDA (0.4× RDA)
13 studies (A:0, B:3)
Sodium
298 mg
Potassium
45 mg
Claims
Label Claims — Verification
Unverified
Nutrient
Info
Product Information
Directions for Use
Must be used under the supervision of a physician.
Formulation Notes
Prescription phosphorous Supplying 250 mg per tablet
Additional Information
NDC 42291-152-01 Peel here
Metadata
Product Details
Research
Research Evidence
46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
B
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
B
Calcium and phosphorus supplementation of human milk for preterm infants
B
Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
B
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
B
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
B
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
B
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
B
Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Compare
Similar Products
Virt-Phos 250 Neutral
Virtus Pharmaceuticals · Tablet or Pill
100
Essential Minerals For Women & Men
Nature's Measure · Tablet or Pill
100
Calcium & Phosphorus With Vitamin D
Sunmark · Tablet or Pill
100
Replace SR
Endurance Products Company · Tablet or Pill
100
Replace SR
Endurance Products Company · Tablet or Pill
100
This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.